High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$1.6M
$1,635,601
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
ANIP
S
ANI PHARMACEUTICALS INC
Mutz Christopher
• Officer • HEAD OF RARE DISEASE
10b5-1 Sell
2026-03-13
$226,526
|
||||||
| ANIP |
ANI PHARMACEUTICALS INC
|
Officer • HEAD OF RARE DISEASE
10b5-1 Sell
|
2026-03-13 | $226,526 | S | Form 4 |
|
ANIP
S
ANI PHARMACEUTICALS INC
Mutz Christopher
• Officer • HEAD OF RARE DISEASE
10b5-1 Sell
2026-03-09
$267,196
|
||||||
| ANIP |
ANI PHARMACEUTICALS INC
|
Officer • HEAD OF RARE DISEASE
10b5-1 Sell
|
2026-03-09 | $267,196 | S | Form 4 |
|
ANIP
S
ANI PHARMACEUTICALS INC
Mutz Christopher
• Officer • HEAD OF RARE DISEASE
10b5-1 Sell
2026-03-06
$157,421
|
||||||
| ANIP |
ANI PHARMACEUTICALS INC
|
Officer • HEAD OF RARE DISEASE
10b5-1 Sell
|
2026-03-06 | $157,421 | S | Form 4 |
|
ANIP
S
ANI PHARMACEUTICALS INC
Mutz Christopher
• Officer • HEAD OF RARE DISEASE
10b5-1 Sell
2026-03-02
$30,858
|
||||||
| ANIP |
ANI PHARMACEUTICALS INC
|
Officer • HEAD OF RARE DISEASE
10b5-1 Sell
|
2026-03-02 | $30,858 | S | Form 4 |
|
ANIP
S
ANI PHARMACEUTICALS INC
Mutz Christopher
• Officer • HEAD OF RARE DISEASE
10b5-1 Sell
2026-02-20
$415,300
|
||||||
| ANIP |
ANI PHARMACEUTICALS INC
|
Officer • HEAD OF RARE DISEASE
10b5-1 Sell
|
2026-02-20 | $415,300 | S | Form 4 |
|
ANIP
S
ANI PHARMACEUTICALS INC
Mutz Christopher
• Officer • HEAD OF RARE DISEASE
10b5-1 Sell
2026-02-12
$538,300
|
||||||
| ANIP |
ANI PHARMACEUTICALS INC
|
Officer • HEAD OF RARE DISEASE
10b5-1 Sell
|
2026-02-12 | $538,300 | S | Form 4 |